Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 20
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

CRISPR-Cas12a genome editing at the whole-plant level using two compatible RNA virus vectors

  • Uranga, Mireia
  • Vázquez-Vilar, Marta
  • Orzáez Calatayud, Diego Vicente
  • Daròs, José-Antonio|||0000-0002-6535-2889
[EN] The use of viral vectors that can replicate and move systemically through the host plant to deliver bacterial CRISPR components enables genome editing at the whole-plant level and avoids the requirement for labor-intensive stable transformation. However, this approach usually relies on previously transformed plants that stably express a CRISPR-Cas nuclease. Here, we describe successful DNA-free genome editing of Nicotiana benthamiana using two compatible RNA virus vectors derived from tobacco etch virus (TEV; genus Potyvirus) and potato virus X (PVX; genus Potexvirus), which replicate in the same cells. The TEV and PVX vectors respectively express a Cas12a nuclease and the corresponding guide RNA. This novel two-virus vector system improves the toolbox for transformation-free virus-induced genome editing in plants and will advance efforts to breed more nutritious, resistant, and productive crops., This research was supported by grants BIO2017-83184-R and PID2019-108203RB-I00 from the Ministerio de Ciencia e Innovacion (Spain) through the Agencia Estatal de Investigacion (co-financed by the European Regional Development Fund) and H2020-760331 Newcotiana from the European Commission. M.U. andM.V.-V. are the recipients of fellowships FPU17/05503 from the Ministerio de Ciencia e Innovacion (Spain) and APOSTD/2020/096 from the Generalitat Valenciana (Spain), respectively
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

PYL1-and PYL8-like ABA Receptors of Nicotiana benthamiana Play a Key Role in ABA Response in Seed and Vegetative Tissue

  • Pizzio, Gaston A.
  • Mayordomo, Cristian
  • Lozano-Juste, Jorge
  • Vazquez-Vilar, Marta
  • Kaminski, Kacper P.
  • Ivanov, Nikolai V.
  • Estevez ,Juan C.
  • Rivera-Moreno, Maria
  • Albert, Armando
  • Rodríguez, Pedro L.
  • García-Carpintero-Burgos, Víctor
  • Nebauer, Sergio G.|||0000-0001-7978-6680
  • Orzáez Calatayud, Diego Vicente
[EN] To face the challenges of climate change and sustainable food production, it is essential to develop crop genome editing techniques to pinpoint key genes involved in abiotic stress signaling. The identification of those prevailing abscisic acid (ABA) receptors that mediate plant-environment interactions is quite challenging in polyploid plants because of the high number of genes in the PYR/PYL/RCAR ABA receptor family. Nicotiana benthamiana is a biotechnological crop amenable to genome editing, and given the importance of ABA signaling in coping with drought stress, we initiated the analysis of its 23-member family of ABA receptors through multiplex CRISPR/Cas9-mediated editing. We generated several high-order mutants impaired in NbPYL1-like and NbPYL8-like receptors, which showed certain insensitivity to ABA for inhibition of seedling establishment, growth, and development of shoot and lateral roots as well as reduced sensitivity to the PYL1-agonist cyanabactin (CB). However, in these high-order mutants, regulation of transpiration was not affected and was responsive to ABA treatment. This reveals a robust and redundant control of transpiration in this allotetraploid plant that probably reflects its origin from the extreme habitat of central Australia., This research was supported by grant PID2020-113100RB (P.L.R.) and PID2020-119805RB (A.A.) funded by MCIN/AEI/10.13039/501100011033 and by Newcotiana H2020 760331 (D.O.).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Strong and tunable anti-CRISPR/Cas activities in plants

  • Calvache-Román, Camilo Alberto
  • Selma, Sara
  • Vázquez-Vilar, Marta
  • Uranga, Mireia
  • Fernandez Del Carmen, Maria Asuncion|||0000-0002-9202-4960
  • Daròs, José-Antonio|||0000-0002-6535-2889
  • Orzáez Calatayud, Diego Vicente
[EN] CRISPR/Cas has revolutionized genome engineering in plants. However, the use of anti-CRISPR proteins as tools to prevent CRISPR/Cas-mediated gene editing and gene activation in plants has not been explored yet. This study describes the characterization of two anti-CRISPR proteins, AcrIIA4 and AcrVA1, in Nicotiana benthamiana. Our results demonstrate that AcrIIA4 prevents site-directed mutagenesis in leaves when transiently co-expressed with CRISPR/Cas9. In a similar way, AcrVA1 is able to prevent CRISPR/Cas12a-mediated gene editing. Moreover, using a N. benthamiana line constitutively expressing Cas9, we show that the viral delivery of AcrIIA4 using Tobacco etch virus is able to completely abolish the high editing levels obtained when the guide RNA is delivered with a virus, in this case Potato virus X. We also show that AcrIIA4 and AcrVA1 repress CRISPR/dCas-based transcriptional activation of reporter genes. In the case of AcrIIA4, this repression occurs in a highly efficient, dose-dependent manner. Furthermore, the fusion of an auxin degron to AcrIIA4 results in auxin-regulated activation of a downstream reporter gene. The strong anti-Cas activity of AcrIIA4 and AcrVA1 reported here opens new possibilities for customized control of gene editing and gene expression in plants., This work has been funded by grants PID2019-108203RB-100, PID2020-114691RB-I00 and BIO2017-83184-R from the Spanish Ministerio de Ciencia e Innovacion, through the Agencia Estatal de Investigacion (co-financed European Regional Development Fund). Calvache, C. is recipient of FPI-UPV (PAID-01-20) fellowship from Universitat Politecnica de Valencia. Vazquez-Vilar, M. is recipient of APOSTD/2020/096 (Generalitat Valenciana and Fondo Social Europeo post-doctoral grant). Selma, S. and Uranga, M. are recipients of FPI (BIO2016-78601-R) H2020 Research Program: 760331 Newcotiana and FPU (FPU17/05503) fellowships, respectively, from Ministerio de Ciencia e Innovacion (Spain).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A copper switch for inducing CRISPR/Cas9-based transcriptional activation tightly regulates gene expression in Nicotiana benthamiana

  • García-Pérez, Elena
  • Diego-Martín, Borja
  • Quijano-Rubio, Alfredo
  • Moreno-Giménez, Elena
  • Selma, Sara
  • Vázquez-Vilar, Marta
  • Orzáez Calatayud, Diego Vicente
[EN] Background CRISPR-based programmable transcriptional activators (PTAs) are used in plants for rewiring gene networks. Better tuning of their activity in a time and dose-dependent manner should allow precise control of gene expression. Here, we report the optimization of a Copper Inducible system called CI-switch for conditional gene activation in Nicotiana benthamiana. In the presence of copper, the copper-responsive factor CUP2 undergoes a conformational change and binds a DNA motif named copper-binding site (CBS). Results In this study, we tested several activation domains fused to CUP2 and found that the non-viral Gal4 domain results in strong activation of a reporter gene equipped with a minimal promoter, offering advantages over previous designs. To connect copper regulation with downstream programmable elements, several copper-dependent configurations of the strong dCasEV2.1 PTA were assayed, aiming at maximizing activation range, while minimizing undesired background expression. The best configuration involved a dual copper regulation of the two protein components of the PTA, namely dCas9:EDLL and MS2:VPR, and a constitutive RNA pol III-driven expression of the third component, a guide RNA with anchoring sites for the MS2 RNA-binding domain. With these optimizations, the CI/dCasEV2.1 system resulted in copper-dependent activation rates of 2,600-fold and 245-fold for the endogenous N. benthamiana DFR and PAL2 genes, respectively, with negligible expression in the absence of the trigger. Conclusions The tight regulation of copper over CI/dCasEV2.1 makes this system ideal for the conditional production of plant-derived metabolites and recombinant proteins in the field., This work has been funded by EU Horizon 2020 Project Newcotiana Grant 760331, PID2019-108203RB-100 Plan Nacional I + D, Spanish Ministry of Economy and Competitiveness and 'ERACoBioTech' Project SUSPHIRE Grant No. 722361. Vazquez-Vilar, M. is recipient of APOSTD/2020/096 (Generalitat Valenciana and Fondo Social Europeo post-doctoral grant). Garcia-Perez, E. is recipient of ACIF-2020 fellowship (Generalitat Valenciana). Diego-Martin, B. and Moreno-Gimenez, E. are recipients of FPU fellowships. Selma, S. is recipient of FPI fellowship.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Comparative analysis of the Squamosa Promoter Binding-Like (SPL) gene family in Nicotiana benthamiana and Nicotiana tabacum

  • De Paola, Carmine
  • Vázquez-Vilar, Marta
  • Kaminski, Kacper
  • Sierro, Nicolas
  • Ivanov, Nikolai V.
  • Giuliano, Giovanni
  • Waterhouse, Peter
  • García-Carpintero-Burgos, Víctor
  • Fernandez Del Carmen, Maria Asuncion|||0000-0002-9202-4960
  • Orzáez Calatayud, Diego Vicente
[EN] SQUAMOSA PROMOTER BINDING-LIKE (SPL) proteins constitute a large family of transcription factors known to play key roles in growth and developmental processes, including juvenile-to-adult and vegetative-to-reproductive phase transitions. This makes SPLs interesting targets for precision breeding in plants of the Nicotiana genus used as e.g. recombinant biofactories. We report the identification of 49 SPL genes in Nicotiana tabacum cv. K326 and 43 SPL genes in Nicotiana benthamiana LAB strain, which were classified into eight phylogenetic groups according to the SPL classification in Arabidopsis. Exon-intron gene structure and DNA-binding domains were highly conserved between homeologues and orthologues. Thirty of the NbSPL genes and 33 of the NtSPL genes were found to be possible targets of microRNA 156. The expression of SPL genes in leaves was analysed by RNA-seq at three different stages, revealing that genes not under miR156 control were in general constitutively expressed at high levels, whereas miR156-regulated genes showed lower expression, often developmentally regulated. We selected the N. benthamiana SPL13_1a gene as target for a CRISPR/Cas9 knock-out experiment. We show here that a full knock-out in this single gene leads to a significant delay in flowering time, a trait that could be exploited to increase biomass for recombinant protein production., This work was supported by grant H2020 - 760331 Newcotiana from the European Commission. C.D and M.V.V are the recipients of fellowships GRISOLIAP/2019/013 and APOSTD/2020/096 from the Generalitat Valenciana (Spain) , respectively.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Identification of Transgene-Free CRISPR-Edited Plants of Rice, Tomato, and Arabidopsis by Monitoring DsRED Fluorescence in Dry Seeds

  • Aliaga Franco, Norma
  • Zhang, Cunjin
  • Srivastava, Anjil K.
  • Sadanandom, Ari
  • Minguet, E.G.
  • Presa Castro, Silvia
  • GRANELL RICHART, ANTONIO|||0000-0003-4266-9581
  • ALABADÍ DIEGO, DAVID|||0000-0001-8492-6713
  • BLAZQUEZ, MIGUEL-ANGEL|||0000-0001-5743-0448
[EN] Efficient elimination of the editing machinery remains a challenge in plant biotechnology after genome editing to minimize the probability of off-target mutations, but it is also important to deliver end users with edited plants free of foreign DNA. Using the modular cloning system Golden Braid, we have included a fluorescence-dependent transgene monitoring module to the genome-editing tool box. We have tested this approach in Solanum lycopersicum, Oryza sativa, and Arabidopsis thaliana. We demonstrate that DsRED fluorescence visualization works efficiently in dry seeds as marker for the detection of the transgene in the three species allowing an efficient method for selecting transgene-free dry seeds. In the first generation of DsRED-free CRISPR/Cas9 null segregants, we detected gene editing of selected targets including homozygous mutants for the plant species tested. We demonstrate that this strategy allows rapid selection of transgene-free homozygous edited crop plants in a single generation after in vitro transformation., Grants AGL2014-57200-JIN (EGM), BFU2016-80621-P (MB), and BIO2016-78601-R (AG) from the current Spanish Ministry of Science, Innovation and Universities. Grants TRADITOM (634561), TomGEM (679796), Newcotiana (760331-2) and Pharma-Factory (SEP-210417525) from European Union H2020 program (AG). ERC grant "SUMOrice" and BBSRC grant "Flooding tolerance in rice" (AS).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

GB_SynP: A Modular dCas9-Regulated Synthetic Promoter Collection for Fine-Tuned Recombinant Gene Expressionin Plants

  • Moreno-Giménez, Elena
  • Selma, Sara
  • Calvache-Román, Camilo Alberto
  • Orzáez Calatayud, Diego Vicente
[EN] Programmable transcriptional factors based on the CRISPR architecture are becoming commonly used in plants for endogenous gene regulation. In plants, a potent CRISPR tool for gene induction is the so-called dCasEV2.1 activation system, which has shown remarkable genome-wide specificity combined with a strong activation capacity. To explore the ability of dCasEV2.1 to act as a transactivator for orthogonal synthetic promoters, a collection of DNA parts was created (GB_SynP) for combinatorial synthetic promoter building. The collection includes (i) minimal promoter parts with the TATA box and 5'UTR regions, (ii) proximal parts containing single or multiple copies of the target sequence for the gRNA, thus functioning as regulatory cis boxes, and (iii) sequence-randomized distal parts that ensure the adequate length of the resulting promoter. A total of 35 promoters were assembled using the GB_SynP collection, showing in all cases minimal background and predictable activation levels depending on the proximal parts used. GB_SynP was also employed in a combinatorial expression analysis of an autoluminescence pathway in Nicotiana benthamiana, showing the value of this tool in extracting important biological information such as the determination of the limiting steps in an enzymatic pathway., This work was funded by Era-CoBiotech SUSPHIRE (PCI2018-092893) and PID2019-108203RB-I00 Plan Nacional I+D, Spanish Ministry of Economy and Competitiveness. E.M.-G. and S.S. acknowledge support by a FPU (FPU18/02019) and a FPI (BIO2016-78601-R) H2020 Research Program: 760331 Newcotiana fellowships, respectively, from the Spanish Ministry of Science, Innovation and Universities. C.C. acknowledges support by a FPI-UPV (PAID-01-20) fellowship from Universitat Politecnica de Valencia. The authors would like to thank Dr. Lynne Yenush for her assistance with the manuscript preparation.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector

  • Uranga-Ruiz De Eguino, Mireia
  • Selma García, Sara
  • Vázquez-Vilar, Marta
  • Aragones, V|||0000-0002-4695-7890
  • Orzáez Calatayud, Diego Vicente
  • Daròs, José-Antonio|||0000-0002-6535-2889
[EN] Systems based on the clustered, regularly interspaced, short palindromic repeat (CRISPR) and CRISPR-associated proteins (Cas) have revolutionized genome editing in many organisms, including plants. Most CRISPR-Cas strategies in plants rely on genetic transformation using Agrobacterium tumefaciens to supply the gene editing reagents, such as Cas nucleases or the synthetic guide RNA (sgRNA). While Cas nucleases are constant elements in editing approaches, sgRNAs are target-specific and a screening process is usually required to identify those most effective. Plant virus-derived vectors are an alternative for the fast and efficient delivery of sgRNAs into adult plants, due to the virus capacity for genome amplification and systemic movement, a strategy known as virus-induced genome editing. We engineered Potato virus X (PVX) to build a vector that easily expresses multiple sgRNAs in adult solanaceous plants. Using the PVX-based vector, Nicotiana benthamiana genes were efficiently targeted, producing nearly 80% indels in a transformed line that constitutively expresses Streptococcus pyogenes Cas9. Interestingly, results showed that the PVX vector allows expression of arrays of unspaced sgRNAs, achieving highly efficient multiplex editing in a few days in adult plant tissues. Moreover, virus-free edited progeny can be obtained from plants regenerated from infected tissues or infected plant seeds, which exhibit a high rate of heritable biallelic mutations. In conclusion, this new PVX vector allows easy, fast and efficient expression of sgRNA arrays for multiplex CRISPR-Cas genome editing and will be a useful tool for functional gene analysis and precision breeding across diverse plant species, particularly in Solanaceae crops., This work was supported by grants BIO2017-83184-R and PID2019-108203RB-I00 from Ministerio de Ciencia e Innovacion (Spain) through the Agencia Estatal de Investigacion (co-financed European Regional Development Fund), and H2020-760331 Newcotiana from the European Commission. M.U. and S.S. are the recipients of fellowships FPU17/05503 and BES-2017-0890098, respectively, from Ministerio de Ciencia e Innovacion (Spain)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

The GB4.0 Platform, an All-In-One Tool for CRISPR/Cas-Based Multiplex Genome Engineering in Plants

  • Vazquez-Vilar, Marta
  • Garcia-Carpintero, Víctor
  • Selma, Sara
  • Bernabé-Orts, Joan M.
  • Sánchez-Vicente, Javier
  • Salazar-Sarasua, Blanca
  • Ressa, Arianna
  • de Paola, Carmine
  • Ajenjo, María
  • Quintela, Jose Carlos
  • Fernandez-del-Carmen, Asun
  • GRANELL RICHART, ANTONIO|||0000-0003-4266-9581
  • Orzáez Calatayud, Diego Vicente
[EN] CRISPR/Cas ability to target several loci simultaneously (multiplexing) is a game-changer in plant breeding. Multiplexing not only accelerates trait pyramiding but also can unveil traits hidden by functional redundancy. Furthermore, multiplexing enhances dCas-based programmable gene expression and enables cascade-like gene regulation. However, the design and assembly of multiplex constructs comprising tandemly arrayed guide RNAs (gRNAs) requires scarless cloning and is still troublesome due to the presence of repetitive sequences, thus hampering a more widespread use. Here we present a comprehensive extension of the software-assisted cloning platform GoldenBraid (GB), in which, on top of its multigene cloning software, we integrate new tools for the Type IIS-based easy and rapid assembly of up to six tandemly-arrayed gRNAs with both Cas9 and Cas12a, using the gRNA-tRNA-spaced and the crRNA unspaced approaches, respectively. As stress tests for the new tools, we assembled and used for Agrobacterium-mediated stable transformation a 17 Cas9-gRNAs construct targeting a subset of the Squamosa-Promoter Binding Protein-Like (SPL) gene family in Nicotiana tabacum. The 14 selected genes are targets of miR156, thus potentially playing an important role in juvenile-to-adult and vegetative-to-reproductive phase transitions. With the 17 gRNAs construct we generated a collection of Cas9-free SPL edited T-1 plants harboring up to 9 biallelic mutations and showing leaf juvenility and more branching. The functionality of GB-assembled dCas9 and dCas12a-based CRISPR/Cas activators and repressors using single and multiplexing gRNAs was validated using a Luciferase reporter with the Solanum lycopersicum Mtb promoter or the Agrobacterium tumefaciens nopaline synthase promoter in transient expression in Nicotiana benthamiana. With the incorporation of the new web-based tools and the accompanying collection of DNA parts, the GB4.0 genome edition turns an all-in-one open platform for plant genome engineering., This work had been funded by EU Horizon 2020 Project Newcotiana Grant 760331 and PID2019-108203RB-100 Plan Nacional I+D, Spanish Ministry of Economy and Competitiveness. MV-V was recipient of aGeneralitat Valenciana and Fondo Social Europeo post-doctoral grant. JB-O and SS were recipients of FPI fellowships. CP was recipient of a Santiago Grisolia fellowship (Generalitat Valenciana).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Production of Saffron Apocarotenoids in Nicotiana benthamiana Plants Genome-Edited to Accumulate Zeaxanthin Precursor

  • Demurtas, Olivia Costantina
  • Sulli, Maria
  • Ferrante, Paola
  • Mini, Paola
  • Marti, Maricarmen
  • Giuliano, Giovanni
  • Aragones, V|||0000-0002-4695-7890
  • Daròs, José-Antonio|||0000-0002-6535-2889
[EN] Crocins are glycosylated apocarotenoids with strong coloring power and anti-oxidant, anticancer, and neuro-protective properties. We previously dissected the saffron crocin biosynthesis pathway, and demonstrated that the CsCCD2 enzyme, catalyzing the carotenoid cleavage step, shows a strong preference for the xanthophyll zeaxanthin in vitro and in bacterio. In order to investigate substrate specificity in planta and to establish a plant-based bio-factory system for crocin production, we compared wild-type Nicotiana benthamiana plants, accumulating various xanthophylls together with & alpha;- and & beta;-carotene, with genome-edited lines, in which all the xanthophylls normally accumulated in leaves were replaced by a single xanthophyll, zeaxanthin. These plants were used as chassis for the production in leaves of saffron apocarotenoids (crocins, picrocrocin) using two transient expression methods to overexpress CsCCD2: agroinfiltration and inoculation with a viral vector derived from tobacco etch virus (TEV). The results indicated the superior performance of the zeaxanthin-accumulating line and of the use of the viral vector to express CsCCD2. The results also suggested a relaxed substrate specificity of CsCCD2 in planta, cleaving additional carotenoid substrates., Work supported by the European Commission, Horizon 2020 program (Project NEWCOTIANA, grant agreement 760331), and the Spanish Ministerio de Ciencia e Innovacion through Agencia Estatal de Investigacion (PID2020-114691RB-I00). MM was the recipient of a predoctoral contract (FPU16/05294) from the Ministerio de Educacion, Cultura y Deporte (Spain).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A multi-omic Nicotiana benthamiana resource for fundamental research and biotechnology

  • Ranawaka, B.
  • An, J.
  • Lorenc, Michal T.
  • Jung, H.
  • Sulli, María
  • Aprea, Giuseppe
  • Roden, Sally
  • Llaca, Victor
  • Orzáez Calatayud, Diego Vicente
  • Bombarely A
[EN] Nicotiana benthamiana is an invaluable model plant and biotechnology platform. To further improve its usefulness and versatility, we have produced high quality chromosome level genome assemblies and multi-omic datasets for both the ubiquitously used LAB strain and a distantly related wild accession, QLD, as well as mapping their single nucleotide polymorphisms with two additional laboratory and four additional wild accessions. LAB and QLD have many genetic, functional, and metabolic differences. These coupled with their high inter-fertility and equally efficient transient and stable transformation and genome editing provide a powerful resource partnership. Their ~3Gb allotetraploid genomes show advanced diploidisation with major chromosome loss and rearrangement, extensive homoeologous gene loss, and widespread segmental allopolyploidy. Recent bursts of Copia mobility, not seen in other Nicotiana genomes, have probably aided N. benthamiana¿s adaptation to a spectrum of Australian ecologies., We thank the Queensland University of Technology High-Performance Computing team for their assistance in genome assembly and hosting the genome browsers. Work was supported by Australian Research Council Federation Fellowship, Laureate Fellowship, Discovery and Centre of Excellence Awards (grants nos FF0776510 to P.M.W., FL160100155 to P.M.W., DP170103960 to P.M.W. and CE200100015 to P.M.W.) and the European Commission Horizon 2020 program, project Developing Multipurpose Nicotiana Crops for Molecular Farming using New Plant Breeding Techniques (NEWCOTIANA)', grant agreement no. 760331 to D.O., A.B., G.G. and P.M.W. and grant no. 101094738 to G.G.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Contributions of the international plant science community to the fight against infectious diseases in humans - part 2: endemic and re-emerging diseases

  • He, Wenshu
  • Baysal, Can
  • Lobato, Maria
  • Huang, Xin
  • Alvarez, Derry
  • Zhu, Changfu
  • Armario-Nájera, Victoria
  • Blanco Perera, Amaya
  • Cerda, Pedro
  • Saba-Mayoral, Andrea
  • Sobrino-Mengual, Guillermo
  • Vargheese, Ashwin
  • Abranches, Rita
  • Abreu, Isabel Alexandra
  • Balamurugan, Shanmugaraj
  • Bock, Ralph
  • Buyel, Johannes F.
  • Cunha, Nicolau B. da
  • Daniell, Henry
  • Faller, Roland
  • Folgado, André
  • Gowtham, Iyappan
  • Häkkinen, Suvi
  • Kumar, Shashi
  • Sathish Kumar, Ramalingam
  • Lacorte, Cristiano
  • Lomonossoff, George P.
  • Luís, Ines M.
  • Ma, Julian K-C
  • McDonald, Karen A.
  • Murad, Andre
  • Nandi, Somen
  • O'Keef, Barry
  • Parthiban, Subramanian
  • Paul, Mathew J.
  • Ponndorf, Daniel
  • Rech, Elibio
  • Rodrigues, Julio C. M.
  • Ruf, Stephanie
  • Schillberg, Stefan
  • Schwestka, Jennifer
  • Shah, Priya S.
  • Singh, Rahul
  • Stoger, Eva
  • Twyman, Richard M.
  • Varghese, Inchakalody P.
  • Vianna, Giovanni R.
  • Webster, Gina
  • Wilbers, Ruud H. P.
  • Christou, Paul
  • Oksman-Caldentey, Kirsi-Marja
  • Capell Capell, Teresa
The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, but also by challenges caused by distribution and storage, particularly in regions without a complete cold chain. In this review article, we consider the potential of molecular farming to address the challenges of endemic and re-emerging diseases, focusing on edible plants for the development of oral drugs. Key recent developments in this field include successful clinical trials based on orally delivered dried leaves of Artemisia annua against malarial parasite strains resistant to artemisinin combination therapy, the ability to produce clinical-grade protein drugs in leaves to treat infectious diseases and the long-term storage of protein drugs in dried leaves at ambient temperatures. Recent FDA approval of the first orally delivered protein drug encapsulated in plant cells to treat peanut allergy has opened the door for the development of affordable oral drugs that can be manufactured and distributed in remote areas without cold storage infrastructure and that eliminate the need for expensive purification steps and sterile delivery by injection., The authors would like to thank the Spanish Ministry of Economy, Industry and Competitiveness (project AGL2017-85377-R), the Spanish Ministry of Science, Innovation and Universities (projects RTI2018-097613-B-I00 and PGC2018-097655-B-I00), the EU Horizon 2020 project Pharma-Factory (774078) and the Gener- alitat de Catalunya (Grups Consolidats2017-SGR828); Ag encia de Gesti o d’Ajuts Universitaris i de Recerca (AGAUR), Departament d’Empresa i Coneixement de la Generalitat de Catalunya (PAND EMIES 2020); Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular funded by FEDER funds through COMPETE2020)—Programa Operacional Compet- itividade e Internacionalizacß~ao (POCI) and by the FCT (Portugal) through the R&D Unit, UIDB/04551/2020 (GREEN-IT—Biore- sources for Sustainability); UKIERI and the Hotung Foundation for sustained support of the Bharathiar University / St. George’s Univ. of London collaboration and the Molecular Immunology Unit at St. George’s Univ. of London. The Max Planck Society, the EU Horizon 2020 project Newcotiana (760331-2) and a grant from the European Research Council (ERC-ADG-2014; grant agreement 669982) to RB. KMOC, RMT and STH acknowledge support from the InnCoCells project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement 101000373. PSS, KAM, RF and SN are partially supported by a CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis. KAM and SN were partially supported by NASA Space Technology Research (award number NNX17AJ31G) and by the Translational Research Institute through NASA (grant number NNX16AO69A); EMBRAPA (Brazilian Agricultural Corporation), INCT BioSyn (National Institute of Science and Technology in Synthetic Biology), CNPq, CAPES, Brazilian Ministry of Health, FAPDFnd Universidade Cat olica de Bras ılia (UCB), Bras ılia, Brazil; BBSRC Grant BB/L020955/1, the JIC Strategic Programme Grant ‘Molecules from Nature –Enhanced Research Capacity’ (BBS/E/ J/000PR9794), the John Innes Foundation and the Department of Health and Social Care using UK Aid funding managed by the BBSRC; and The Austrian Science Fund FWF (project W1224). TTW Veni Grant 16740 from the Netherlands Organization for Scientific Research. Research in the Daniell laboratory was supported by NIH grants R01 GM 63879, R01 107904, R01 HL 109442, R01 133191 and grants from Bayer, Novo Nordisk and Shire/Takeda. The National Heart Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, through the Science Moving TowArds Research Trans- lation and Therapy (SMARTT) programme contracts # HHSN268201600014C, HHSN268201600011C supported IND enabling regulatory, toxicology and pharmacokinetic studies. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the University of California, Davis, National Aeronautics and Space Administration (NASA) or the Translational Research Institute for Space Health (TRISH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Views expressed in this article are those of the authors and do not necessarily reflect those of the employing institutions or the UK Department of Health and Social Care
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Contributions of the international plant science community to the fight against infectious diseases in humans - part 1: epidemic and pandemic diseases, including HIV/AIDS and coronaviruses

  • Lobato, Maria
  • Huang, Xin
  • Alvarez, Derry
  • He, Wenshu
  • Baysal, Can
  • Zhu, Changfu
  • Armario-Nájera, Victoria
  • Blanco Perera, Amaya
  • Cerda, Pedro
  • Saba-Mayoral, Andrea
  • Sobrino-Mengual, Guillermo
  • Vargheese, Ashwin
  • Abranches, Rita
  • Abreu, Isabel Alexandra
  • Balamurugan, Shanmugaraj
  • Bock, Ralph
  • Buyel, Johannes F.
  • Cunha, Nicolau B. da
  • Daniell, Henry
  • Faller, Roland
  • Folgado, André
  • Gowtham, Iyappan
  • Häkkinen, Suvi
  • Kumar, Shashi
  • Sathish Kumar, Ramalingam
  • Lacorte, Cristiano
  • Lomonossoff, George P.
  • Luís, Ines M.
  • Ma, Julian K-C
  • McDonald, Karen A.
  • Murad, Andre
  • Nandi, Somen
  • O'Keef, Barry
  • Oksman-Caldentey, Kirsi-Marja
  • Parthiban, Subramanian
  • Paul, Mathew J.
  • Ponndorf, Daniel
  • Rech, Elibio
  • Rodrigues, Julio C. M.
  • Ruf, Stephanie
  • Schillberg, Stefan
  • Schwestka, Jennifer
  • Shah, Priya S.
  • Singh, Rahul
  • Stoger, Eva
  • Twyman, Richard M.
  • Varghese, Inchakalody P.
  • Vianna, Giovanni R.
  • Webster, Gina
  • Wilbers, Ruud H. P.
  • Capell Capell, Teresa
  • Christou, Paul
Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause 17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccination programmes, hygiene measures and drugs that suppress the pathogen, treat the disease symptoms or attenuate aggressive reactions of the host immune system. The provision of vaccines and biologic drugs such as antibodies is hampered by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, particularly in developing countries where infectious diseases are prevalent and poorly controlled. Molecular farming, which uses plants for protein expression, is a promising strategy to address the drawbacks of current manufacturing platforms. In this review article, we consider the potential of molecular farming to address healthcare demands for the most prevalent and important epidemic and pandemic diseases, focussing on recent outbreaks of high-mortality coronavirus infections and diseases that disproportionately affect the developing world., The authors would like to thank the Spanish Ministry of Economy, Industry and Competitiveness (project AGL2017-85377-R), the Spanish Ministry of Science, Innovation and Universities (projects RTI2018-097613-B-I00 and PGC2018-097655-B-I00), the EU Horizon 2020 project Pharma-Factory (774078) and the Gener- alitat de Catalunya (Grups Consolidats 2017-SGR828), Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), Departa- ment d’Empresa i Coneixement de la Generalitat de Catalunya (PAND EMIES 2020). Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular funded by FEDER funds through COMPETE2020 –Programa Operacional Compet- itividade e Internacionalizacß~ao (POCI) and by the FCT (Portugal) through the R&D Unit, UIDB/04551/2020 (GREEN-IT –Biore- sources for Sustainability). UKIERI and the Hotung Foundation for sustained support of the Bharathiar University / St. George’s Univ. of London collaboration and the Molecular Immunology Unit at St. George’s Univ of London. The Max Planck Society, the EU Horizon 2020 project Newcotiana, 760331-2) and a grant from the European Research Council (ERC-ADG-2014; grant agree- ment 669982) to RB. KMOC, RMT and STH acknowledge support from the InnCoCells project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement 101000373. PSS, KAM, RF, and SN are partially supported by a CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis. KAM and SN were partially supported by NASA Space Technology Research (award number NNX17AJ31G) and by the Translational Research Institute through NASA (grant number NNX16AO69A). EMBRAPA (Brazilian Agricultural Corporation), INCT BioSyn (National Institute of Science and Technology in Synthetic Biology), CNPq, CAPES, Brazilian Ministry of Health, FAPDF and Universidade Cat olica de Bras ılia (UCB), Bras ılia, Brazil. BBSRC Grant BB/L020955/1, the JIC Strategic Programme Grant ‘Molecules from Nature –Enhanced Research Capacity’ (BBS/E/ J/000PR9794), the John Innes Foundation and the Department of Health and Social Care using UK Aid funding managed by the BBSRC. The Austrian Science Fund FWF (project W1224). TTW Veni Grant 16740 from the Netherlands Organization for Scientific Research. Research in the Daniell laboratory was supported by NIH grants R01 GM 63879, R01 107904, R01 HL 109442, R01 133191 and grants from Bayer, Novo Nordisk and Shire/Takeda. The National Heart Lung and Blood Institute, National Institutes of Health, Department of Healthand Human Services, through the Science Moving TowArds Research Trans- lation and Therapy (SMARTT) program contracts # HHSN268201600014C, HHSN268201600011C supported IND enabling regulatory, toxicology and pharmacokinetic studies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the University of California, Davis, National Aeronautics and Space Administration (NASA) or the Translational Research Institute for Space Health (TRISH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Views expressed in this article are those of the authors and do not necessarily reflect those of the employing institutions or the UK Department of Health and Social Care.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Pilot production of SARS-CoV-2 related proteins in plants: a proof of concept for rapid repurposing of indoors farms into biomanufacturing facilities

  • Diego-Martin, Borja
  • González, Beatriz
  • Vázquez-Vilar, Marta
  • Selma, Sara
  • Mateos-Fernández, Rubén
  • Gianoglio, Silvia
  • Fernández-del-Carmen, Asun
  • Orzáez, Diego
The current CoVid-19 crisis is revealing the strengths and the weaknesses of the world's capacity to respond to a global health crisis. A critical weakness has resulted from the excessive centralization of the current biomanufacturing capacities, a matter of great concern, if not a source of nationalistic tensions. On the positive side, scientific data and information have been shared at an unprecedented speed fuelled by the preprint phenomena, and this has considerably strengthened our ability to develop new technology-based solutions. In this work we explore how, in a context of rapid exchange of scientific information, plant biofactories can serve as a rapid and easily adaptable solution for local manufacturing of bioreagents, more specifically recombinant antibodies. For this purpose, we tested our ability to produce, in the framework of an academic lab and in a matter of weeks, milligram amounts of six different recombinant monoclonal antibodies against SARS-CoV-2 in Nicotiana benthamiana. For the design of the antibodies we took advantage, among other data sources, of the DNA sequence information made rapidly available by other groups in preprint publications. mAbs were all engineered as single-chain fragments fused to a human gamma Fc and transiently expressed using a viral vector. In parallel, we also produced the recombinant SARS-CoV-2 N protein and its Receptor Binding Domain (RBD) in planta and used them to test the binding specificity of the recombinant mAbs. Finally, for two of the antibodies we assayed a simple scale-up production protocol based on the extraction of apoplastic fluid. Our results indicate that gram amounts of anti-SARS-CoV-2 antibodies could be easily produced in little more than 6 weeks in repurposed greenhouses with little infrastructure requirements using N. benthamiana as production platform. Similar procedures could be easily deployed to produce diagnostic reagents and, eventually, could be adapted for rapid therapeutic responses., This work was supported by H2020 EU projects 760331 Newcotiana and 774078 PharmaFactory. S.S. is recipient of a FPI fellowship BIO2016‐78601‐R from the Spanish Ministry of Science and Competitiveness and R.M. is recipient of a GVA fellowship (ACIF/2019/226)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pilot Production of SARS-CoV-2 Related Proteins in Plants: A Proof of Concept for Rapid Repurposing of Indoor Farms Into Biomanufacturing Facilities

  • Diego-Martin, Borja
  • González, Beatriz
  • Vázquez-Vilar, Marta
  • Selma, Sara
  • Mateos-Fernández, Rubén
  • Gianoglio, Silvia
  • Fernández-del-Carmen, Asun
  • Orzáez, Diego
Disponible también versión preprint: http://hdl.handle.net/10261/221118, The current CoVid-19 crisis is revealing the strengths and the weaknesses of the world’s capacity to respond to a global health crisis. A critical weakness has resulted from the excessive centralization of the current biomanufacturing capacities, a matter of great concern, if not a source of nationalistic tensions. On the positive side, scientific data and information have been shared at an unprecedented speed fuelled by the preprint phenomena, and this has considerably strengthened our ability to develop new technology-based solutions. In this work, we explore how, in a context of rapid exchange of scientific information, plant biofactories can serve as a rapid and easily adaptable solution for local manufacturing of bioreagents, more specifically recombinant antibodies. For this purpose, we tested our ability to produce, in the framework of an academic lab and in a matter of weeks, milligram amounts of six different recombinant monoclonal antibodies against SARS-CoV-2 in Nicotiana benthamiana. For the design of the antibodies, we took advantage, among other data sources, of the DNA sequence information made rapidly available by other groups in preprint publications. mAbs were engineered as single-chain fragments fused to a human gamma Fc and transiently expressed using a viral vector. In parallel, we also produced the recombinant SARS-CoV-2 N protein and the receptor binding domain (RBD) of the Spike protein in planta and used them to test the binding specificity of the recombinant mAbs. Finally, for two of the antibodies, we assayed a simple scale-up production protocol based on the extraction of apoplastic fluid. Our results indicate that gram amounts of anti-SARS-CoV-2 antibodies could be easily produced in little more than 6 weeks in repurposed greenhouses with little infrastructure requirements using N. benthamiana as production platform. Similar procedures could be easily deployed to produce diagnostic reagents and, eventually, could be adapted for rapid therapeutic responses., This work was supported by H2020 EU projects 760331 Newcotiana and 774078 PharmaFactory. SS is recipient of a FPI fellowship BIO2016–78601-R from the Spanish Ministry of Science and Competitiveness and RM-F is recipient of a GVA fellowship (ACIF/2019/226)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

PYL1- and PYL8-like ABA Receptors of Nicotiana benthamiana Play a Key Role in ABA Response in Seed and Vegetative Tissue

  • Pizzio, Gaston A.
  • Mayordomo, Cristian
  • Lozano-Juste, Jorge
  • García-Carpintero, Víctor
  • Vázquez-Vilar, Marta
  • Nebauer, Sergio G.
  • Kaminski, Kacper P.
  • Ivanov, Nikolai V.
  • Estévez, Juan C.
  • Rivera-Moreno, María
  • Albert, Armando
  • Orzáez, Diego
  • Rodríguez, Pedro L.
19 pags., 7 figs., 3 tabs. -- This article belongs to the Special Issue Drought and Heat Stress Signalling Responses in Plants, To face the challenges of climate change and sustainable food production, it is essential to develop crop genome editing techniques to pinpoint key genes involved in abiotic stress signaling. The identification of those prevailing abscisic acid (ABA) receptors that mediate plant-environment interactions is quite challenging in polyploid plants because of the high number of genes in the PYR/PYL/RCAR ABA receptor family. Nicotiana benthamiana is a biotechnological crop amenable to genome editing, and given the importance of ABA signaling in coping with drought stress, we initiated the analysis of its 23-member family of ABA receptors through multiplex CRISPR/Cas9-mediated editing. We generated several high-order mutants impaired in NbPYL1-like and NbPYL8-like receptors, which showed certain insensitivity to ABA for inhibition of seedling establishment, growth, and development of shoot and lateral roots as well as reduced sensitivity to the PYL1-agonist cyanabactin (CB). However, in these high-order mutants, regulation of transpiration was not affected and was responsive to ABA treatment. This reveals a robust and redundant control of transpiration in this allotetraploid plant that probably reflects its origin from the extreme habitat of central Australia., This research was supported by grant PID2020-113100RB (P.L.R.) and PID2020-119805RB (A.A.) funded by MCIN/AEI/10.13039/501100011033 and by Newcotiana H2020 760331 (D.O.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A redundant transcription factor network steers spatiotemporal Arabidopsis triterpene synthesis

  • Nguyen, Trang Hieu
  • Thiers, Louis
  • Van Moerkercke, Alex
  • Bai, Yuechen
  • Fernández-Calvo, Patricia
  • Minne, Max
  • Depuydt, Thomas
  • Colinas, Maite
  • Verstaen, Kevin
  • Van Isterdael, Gert
  • Nützmann, Hans-Wilhelm
  • Osbourn, Anne
  • Saeys, Yvan
  • De Rybel, Bert
  • Vandepoele, Klaas
  • Ritter, Andrés
  • Goossens, Alain
25 Pág., Plant specialized metabolites modulate developmental and ecological functions and comprise many therapeutic and other high-value compounds. However, the mechanisms determining their cell-specific expression remain unknown. Here we describe the transcriptional regulatory network that underlies cell-specific biosynthesis of triterpenes in Arabidopsis thaliana root tips. Expression of thalianol and marneral biosynthesis pathway genes depends on the phytohormone jasmonate and is limited to outer tissues. We show that this is promoted by the activity of redundant bHLH-type transcription factors from two distinct clades and coactivated by homeodomain factors. Conversely, the DOF-type transcription factor DAG1 and other regulators prevent expression of the triterpene pathway genes in inner tissues. We thus show how precise expression of triterpene biosynthesis genes is determined by a robust network of transactivators, coactivators and counteracting repressors., This Article was written in loving memory of A. Van Moerkercke (1979–2021). The authors thank A. Bleys for critically reading the manuscript; D. Gasperini for kindly sharing the ProMYCs:NLS-VENUS reporter lines, and P. Vittorioso for the dag1 mutant, ProDAG1:GUS and DAG1 over-expressing lines; J. R. Wendrich and T. Eekhout for assistance in the launching and analysis of the scRNAseq experiment; and S. Desmet and G. Goeminne from the VIB Metabolomics Core – Ghent for the thalianol profiling. This work was supported by the European Community’s Seventh Framework Program (FP7/2007–2013) under grant agreement 613692-TriForC and H2020 Program under grant agreement 760331-Newcotiana to A.G.; the Special Research Fund from Ghent University to A.G. and A.R. (project BOF18/GOA/013), and M.M. (project BOF20/GOA/012); the Flemish Government (AI Research program) to Y.S.; the Research Foundation Flanders with research project grants to A.G. (G004515N and G008417N) and a postdoctoral fellowship to P.F.-C.; a Swiss National Science Foundation postdoctoral fellowship (P300PA_177831) to M.C.; and a China Scholarship Council PhD scholarship to Y.B. A.O. acknowledges funding support from the John Innes Foundation and the BBSRC Institute Strategic Program Grant ‘Molecules from Nature – Products and Pathways’ (BBS/E/J/000PR9790)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Production of Saffron Apocarotenoids in Nicotiana benthamiana Plants Genome-Edited to Accumulate Zeaxanthin Precursor

  • Demurtas, Olivia Costantina
  • Sulli, María
  • Ferrante, Paola
  • Mini, Paola
  • Martí, Maricarmen
  • Aragonés, Verónica
  • Daròs Arnau, José Antonio
  • Giuliano, Giovanni
Abstract Crocins are glycosylated apocarotenoids with strong coloring power and anti-oxidant, anticancer, and neuro-protective properties. We previously dissected the saffron crocin biosynthesis pathway, and demonstrated that the CsCCD2 enzyme, catalyzing the carotenoid cleavage step, shows a strong preference for the xanthophyll zeaxanthin in vitro and in bacterio. In order to investigate substrate specificity in planta and to establish a plant-based bio-factory system for crocin production, we compared wild-type Nicotiana benthamiana plants, accumulating various xanthophylls together with α- and β-carotene, with genome-edited lines, in which all the xanthophylls normally accumulated in leaves were replaced by a single xanthophyll, zeaxanthin. These plants were used as chassis for the production in leaves of saffron apocarotenoids (crocins, picrocrocin) using two transient expression methods to overexpress CsCCD2: agroinfiltration and inoculation with a viral vector derived from tobacco etch virus (TEV). The results indicated the superior performance of the zeaxanthin-accumulating line and of the use of the viral vector to express CsCCD2. The results also suggested a relaxed substrate specificity of CsCCD2 in planta, cleaving additional carotenoid substrates., Work supported by the European Commission, Horizon 2020 program (Project NEWCOTIANA, grant agreement 760331), and the Spanish Ministerio de Ciencia e Innovación through Agencia Estatal de Investigación (PID2020-114691RB-I00). MM was the recipient of a predoctoral contract (FPU16/05294) from the Ministerio de Educación, Cultura y Deporte (Spain)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Contributions of the international plant science community to the fight against infectious diseases in humans - part 2: endemic and re-emerging diseases

  • He, Wenshu
  • Baysal, Can
  • Lobato, Maria
  • Huang, Xin
  • Alvarez, Derry
  • Zhu, Changfu
  • Armario-Nájera, Victoria
  • Blanco Perera, Amaya
  • Cerda, Pedro
  • Saba-Mayoral, Andrea
  • Sobrino-Mengual, Guillermo
  • Vargheese, Ashwin
  • Abranches, Rita
  • Abreu, Isabel Alexandra
  • Balamurugan, Shanmugaraj
  • Bock, Ralph
  • Buyel, Johannes F.
  • Cunha, Nicolau B. da
  • Daniell, Henry
  • Faller, Roland
  • Folgado, André
  • Gowtham, Iyappan
  • Häkkinen, Suvi
  • Kumar, Shashi
  • Sathish Kumar, Ramalingam
  • Lacorte, Cristiano
  • Lomonossoff, George P.
  • Luís, Ines M.
  • Ma, Julian K-C
  • McDonald, Karen A.
  • Murad, Andre
  • Nandi, Somen
  • O'Keef, Barry
  • Parthiban, Subramanian
  • Paul, Mathew J.
  • Ponndorf, Daniel
  • Rech, Elibio
  • Rodrigues, Julio C. M.
  • Ruf, Stephanie
  • Schillberg, Stefan
  • Schwestka, Jennifer
  • Shah, Priya S.
  • Singh, Rahul
  • Stoger, Eva
  • Twyman, Richard M.
  • Varghese, Inchakalody P.
  • Vianna, Giovanni R.
  • Webster, Gina
  • Wilbers, Ruud H. P.
  • Christou, Paul
  • Oksman-Caldentey, Kirsi-Marja
  • Capell Capell, Teresa
The fight against infectious diseases often focuses on epidemics and pandemics, which demand urgent resources and command attention from the health authorities and media. However, the vast majority of deaths caused by infectious diseases occur in endemic zones, particularly in developing countries, placing a disproportionate burden on underfunded health systems and often requiring international interventions. The provision of vaccines and other biologics is hampered not only by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, but also by challenges caused by distribution and storage, particularly in regions without a complete cold chain. In this review article, we consider the potential of molecular farming to address the challenges of endemic and re-emerging diseases, focusing on edible plants for the development of oral drugs. Key recent developments in this field include successful clinical trials based on orally delivered dried leaves of Artemisia annua against malarial parasite strains resistant to artemisinin combination therapy, the ability to produce clinical-grade protein drugs in leaves to treat infectious diseases and the long-term storage of protein drugs in dried leaves at ambient temperatures. Recent FDA approval of the first orally delivered protein drug encapsulated in plant cells to treat peanut allergy has opened the door for the development of affordable oral drugs that can be manufactured and distributed in remote areas without cold storage infrastructure and that eliminate the need for expensive purification steps and sterile delivery by injection., The authors would like to thank the Spanish Ministry of Economy, Industry and Competitiveness (project AGL2017-85377-R), the Spanish Ministry of Science, Innovation and Universities (projects RTI2018-097613-B-I00 and PGC2018-097655-B-I00), the EU Horizon 2020 project Pharma-Factory (774078) and the Gener- alitat de Catalunya (Grups Consolidats2017-SGR828); Ag encia de Gesti o d’Ajuts Universitaris i de Recerca (AGAUR), Departament d’Empresa i Coneixement de la Generalitat de Catalunya (PAND EMIES 2020); Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular funded by FEDER funds through COMPETE2020)—Programa Operacional Compet- itividade e Internacionalizacß~ao (POCI) and by the FCT (Portugal) through the R&D Unit, UIDB/04551/2020 (GREEN-IT—Biore- sources for Sustainability); UKIERI and the Hotung Foundation for sustained support of the Bharathiar University / St. George’s Univ. of London collaboration and the Molecular Immunology Unit at St. George’s Univ. of London. The Max Planck Society, the EU Horizon 2020 project Newcotiana (760331-2) and a grant from the European Research Council (ERC-ADG-2014; grant agreement 669982) to RB. KMOC, RMT and STH acknowledge support from the InnCoCells project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement 101000373. PSS, KAM, RF and SN are partially supported by a CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis. KAM and SN were partially supported by NASA Space Technology Research (award number NNX17AJ31G) and by the Translational Research Institute through NASA (grant number NNX16AO69A); EMBRAPA (Brazilian Agricultural Corporation), INCT BioSyn (National Institute of Science and Technology in Synthetic Biology), CNPq, CAPES, Brazilian Ministry of Health, FAPDFnd Universidade Cat olica de Bras ılia (UCB), Bras ılia, Brazil; BBSRC Grant BB/L020955/1, the JIC Strategic Programme Grant ‘Molecules from Nature –Enhanced Research Capacity’ (BBS/E/ J/000PR9794), the John Innes Foundation and the Department of Health and Social Care using UK Aid funding managed by the BBSRC; and The Austrian Science Fund FWF (project W1224). TTW Veni Grant 16740 from the Netherlands Organization for Scientific Research. Research in the Daniell laboratory was supported by NIH grants R01 GM 63879, R01 107904, R01 HL 109442, R01 133191 and grants from Bayer, Novo Nordisk and Shire/Takeda. The National Heart Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, through the Science Moving TowArds Research Trans- lation and Therapy (SMARTT) programme contracts # HHSN268201600014C, HHSN268201600011C supported IND enabling regulatory, toxicology and pharmacokinetic studies. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the University of California, Davis, National Aeronautics and Space Administration (NASA) or the Translational Research Institute for Space Health (TRISH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Views expressed in this article are those of the authors and do not necessarily reflect those of the employing institutions or the UK Department of Health and Social Care
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Contributions of the international plant science community to the fight against infectious diseases in humans - part 1: epidemic and pandemic diseases, including HIV/AIDS and coronaviruses

  • Lobato, Maria
  • Huang, Xin
  • Alvarez, Derry
  • He, Wenshu
  • Baysal, Can
  • Zhu, Changfu
  • Armario-Nájera, Victoria
  • Blanco Perera, Amaya
  • Cerda, Pedro
  • Saba-Mayoral, Andrea
  • Sobrino-Mengual, Guillermo
  • Vargheese, Ashwin
  • Abranches, Rita
  • Abreu, Isabel Alexandra
  • Balamurugan, Shanmugaraj
  • Bock, Ralph
  • Buyel, Johannes F.
  • Cunha, Nicolau B. da
  • Daniell, Henry
  • Faller, Roland
  • Folgado, André
  • Gowtham, Iyappan
  • Häkkinen, Suvi
  • Kumar, Shashi
  • Sathish Kumar, Ramalingam
  • Lacorte, Cristiano
  • Lomonossoff, George P.
  • Luís, Ines M.
  • Ma, Julian K-C
  • McDonald, Karen A.
  • Murad, Andre
  • Nandi, Somen
  • O'Keef, Barry
  • Oksman-Caldentey, Kirsi-Marja
  • Parthiban, Subramanian
  • Paul, Mathew J.
  • Ponndorf, Daniel
  • Rech, Elibio
  • Rodrigues, Julio C. M.
  • Ruf, Stephanie
  • Schillberg, Stefan
  • Schwestka, Jennifer
  • Shah, Priya S.
  • Singh, Rahul
  • Stoger, Eva
  • Twyman, Richard M.
  • Varghese, Inchakalody P.
  • Vianna, Giovanni R.
  • Webster, Gina
  • Wilbers, Ruud H. P.
  • Capell Capell, Teresa
  • Christou, Paul
Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause 17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccination programmes, hygiene measures and drugs that suppress the pathogen, treat the disease symptoms or attenuate aggressive reactions of the host immune system. The provision of vaccines and biologic drugs such as antibodies is hampered by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, particularly in developing countries where infectious diseases are prevalent and poorly controlled. Molecular farming, which uses plants for protein expression, is a promising strategy to address the drawbacks of current manufacturing platforms. In this review article, we consider the potential of molecular farming to address healthcare demands for the most prevalent and important epidemic and pandemic diseases, focussing on recent outbreaks of high-mortality coronavirus infections and diseases that disproportionately affect the developing world., The authors would like to thank the Spanish Ministry of Economy, Industry and Competitiveness (project AGL2017-85377-R), the Spanish Ministry of Science, Innovation and Universities (projects RTI2018-097613-B-I00 and PGC2018-097655-B-I00), the EU Horizon 2020 project Pharma-Factory (774078) and the Gener- alitat de Catalunya (Grups Consolidats 2017-SGR828), Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), Departa- ment d’Empresa i Coneixement de la Generalitat de Catalunya (PAND EMIES 2020). Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular funded by FEDER funds through COMPETE2020 –Programa Operacional Compet- itividade e Internacionalizacß~ao (POCI) and by the FCT (Portugal) through the R&D Unit, UIDB/04551/2020 (GREEN-IT –Biore- sources for Sustainability). UKIERI and the Hotung Foundation for sustained support of the Bharathiar University / St. George’s Univ. of London collaboration and the Molecular Immunology Unit at St. George’s Univ of London. The Max Planck Society, the EU Horizon 2020 project Newcotiana, 760331-2) and a grant from the European Research Council (ERC-ADG-2014; grant agree- ment 669982) to RB. KMOC, RMT and STH acknowledge support from the InnCoCells project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement 101000373. PSS, KAM, RF, and SN are partially supported by a CRAFT award (COVID-19 Research Accelerator Funding Track) by the University of California Davis. KAM and SN were partially supported by NASA Space Technology Research (award number NNX17AJ31G) and by the Translational Research Institute through NASA (grant number NNX16AO69A). EMBRAPA (Brazilian Agricultural Corporation), INCT BioSyn (National Institute of Science and Technology in Synthetic Biology), CNPq, CAPES, Brazilian Ministry of Health, FAPDF and Universidade Cat olica de Bras ılia (UCB), Bras ılia, Brazil. BBSRC Grant BB/L020955/1, the JIC Strategic Programme Grant ‘Molecules from Nature –Enhanced Research Capacity’ (BBS/E/ J/000PR9794), the John Innes Foundation and the Department of Health and Social Care using UK Aid funding managed by the BBSRC. The Austrian Science Fund FWF (project W1224). TTW Veni Grant 16740 from the Netherlands Organization for Scientific Research. Research in the Daniell laboratory was supported by NIH grants R01 GM 63879, R01 107904, R01 HL 109442, R01 133191 and grants from Bayer, Novo Nordisk and Shire/Takeda. The National Heart Lung and Blood Institute, National Institutes of Health, Department of Healthand Human Services, through the Science Moving TowArds Research Trans- lation and Therapy (SMARTT) program contracts # HHSN268201600014C, HHSN268201600011C supported IND enabling regulatory, toxicology and pharmacokinetic studies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author (s) and do not necessarily reflect the views of the University of California, Davis, National Aeronautics and Space Administration (NASA) or the Translational Research Institute for Space Health (TRISH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Views expressed in this article are those of the authors and do not necessarily reflect those of the employing institutions or the UK Department of Health and Social Care.